Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omax Health is a U.S.-based consumer health and nutraceutical company that develops and markets science-based wellness products rather than prescription therapeutics. Its portfolio includes omega-3 supplements under Omax3, topical pain-relief and CBD/hemp products under CryoFreeze, women's wellness products under O-Shot, and newer cellular health products such as Cellmax. The company was founded in 2008 and positions its products for recovery, pain management, heart and joint support, brain health, immune support, and everyday wellness. Omax Health appears to operate primarily through direct-to-consumer e-commerce and practitioner/retail channels. It is now part of Basic Brands and remains an active commercial brand within that portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omax Health.